These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 2569995

  • 1. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T, Blog FB, Westerhof W, Jansen FC, Starink TM, den Boer MS, Kuneman JJ, Harvey SG, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [Abstract] [Full Text] [Related]

  • 2. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP, Harvey SG, Calthrop JG, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [Abstract] [Full Text] [Related]

  • 3. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
    Boyle J, Marks P, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004
    [Abstract] [Full Text] [Related]

  • 4. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria.
    Leyh F, Harvey SG, Gibson JR, Manna VK.
    J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997
    [Abstract] [Full Text] [Related]

  • 5. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE, Harvey SG, Calthrop JG, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [Abstract] [Full Text] [Related]

  • 6. French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis.
    Gervais P, Bruttman G, Pedrali P, Charpin J, Michel FB, Grilliat JP.
    J Int Med Res; 1989; 17 Suppl 2():47B-53B. PubMed ID: 2570002
    [Abstract] [Full Text] [Related]

  • 7. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study.
    Kobza Black A, Aboobaker J, Gibson JR, Harvey SG, Marks P.
    Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496
    [Abstract] [Full Text] [Related]

  • 8. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P, Manna VK, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [Abstract] [Full Text] [Related]

  • 9. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB, Ellis CN, Grossman J, Washburne WF, Gupta AK, Ball R, Shulan D.
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [Abstract] [Full Text] [Related]

  • 10. A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
    Salisbury J, Bor S, Blair C.
    Br J Clin Pract; 1987 Aug; 41(8):859-61. PubMed ID: 2896512
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
    Paul E, Bödeker RH.
    Z Hautkr; 1985 Aug; 60 Suppl 1():50-5. PubMed ID: 2859714
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria.
    Neittaanmäki H, Fräki JE, Gibson JR.
    Dermatologica; 1988 Aug; 177(2):98-103. PubMed ID: 2901993
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.
    Rolan PE, Adams J, Posner J.
    J Int Med Res; 1989 Aug; 17 Suppl 2():35B-39B. PubMed ID: 2570000
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
    Paul E, Bödeker RH.
    Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
    [Abstract] [Full Text] [Related]

  • 15. Prolonged treatment with acrivastine for seasonal allergic rhinitis.
    Bruno G, D'Amato G, Del Giacco GS, Locci F, Gale NM, Errigo E, Melillo G.
    J Int Med Res; 1989 Apr; 17 Suppl 2():40B-46B. PubMed ID: 2570001
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
    Belaich S, Bruttmann G, DeGreef H, Lachapelle JM, Paul E, Pedrali P, Tennstedt D.
    Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
    [Abstract] [Full Text] [Related]

  • 17. Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily.
    Allergy; 1989 Sep; 44(7):447-52. PubMed ID: 2573286
    [Abstract] [Full Text] [Related]

  • 18. Acrivastine in allergic rhinitis: a review of clinical experience.
    Bojkowski CJ, Gibbs TG, Hellstern KH, Major EW, Mullinger B.
    J Int Med Res; 1989 Sep; 17 Suppl 2():54B-68B. PubMed ID: 2570003
    [Abstract] [Full Text] [Related]

  • 19. Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria.
    Paul E, Reinel D, Ulrich R, Köhler ME.
    Ann Allergy; 1989 Oct; 63(4):340-2. PubMed ID: 2572189
    [Abstract] [Full Text] [Related]

  • 20. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.
    Brogden RN, McTavish D.
    Drugs; 1991 Jun; 41(6):927-40. PubMed ID: 1715267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.